Arca
Skip to content
Tools
Tools

Adrenergic receptor beta

Family in Homo sapiens that 4 drugs act on.

  • Drugs that act on it: 4
  • Approved: 4
  • In phases 1 to 3: 0
  • Sponsors: 2
  • Genes: 3

Who is on it, and how far along

Every drug ChEMBL records acting on ADRB1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 4

Approved4

  • Carvedilol
  • Isoproterenol
  • Dilevalol
  • Carteolol

Phase 30

    Phase 20

      Phase 10

        Sponsors

        Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 3 of 4 act as: Adrenergic receptor beta antagonist; the rest name their own mechanism.
        CarvedilolApprovedGSKSmall moleculeAntagonist52
        IsoproterenolApproved—Small moleculeAgonistAdrenergic receptor beta agonist16
        DilevalolWithdrawnApproved—Small moleculeAntagonist5
        CarteololApprovedAbbVieSmall moleculeAntagonist0

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 21 in all, from ClinicalTrials.gov.
        "Anticipant"-TIPS After a First Portal-hypertension-related Complication in CirrhosisCarvedilolNot applicableNot yet recruitingUniversity Hospital, ToulouseOct 22, 2026
        Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in CirrhosisCarvedilolNot applicableNot yet recruitingWest China HospitalMay 14, 2026
        Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary SyndromeCarvedilolNot applicableNot yet recruitingSeoul National University HospitalMay 11, 2026
        Apixaban-PK Trial: Preventing Portal Hypertension Complications in CirrhosisCarvedilolPhase 4RecruitingAsian Institute Of Medical SciencesApr 9, 2026
        The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.CarvedilolPhase 4RecruitingZiekenhuis Oost-LimburgApr 7, 2026
        Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis.CarvedilolNot applicableNot yet recruitingInstitute of Liver and Biliary Sciences, IndiaMar 12, 2026
        Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of Cirrhotic VaricesCarvedilolPhase 4Enrolling by invitationXijing HospitalJan 20, 2026
        TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal HypertensionCarvedilolPhase 2Not yet recruitingTongji HospitalJan 20, 2026
        Does Vitamin C Increase the Body Heat Generated By The Nervous System?IsoproterenolNot applicableActive, not recruitingColorado State UniversityJan 14, 2026
        Endothelial Dysfunction After SCIIsoproterenol—RecruitingCraig HospitalNov 13, 2025
        Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord InjuryIsoproterenol—RecruitingCraig HospitalNov 13, 2025
        EXPORT Randomized TrialIsoproterenolNot applicableNot yet recruitingYonsei UniversitySep 30, 2025
        Dexmedetomidine vs Labetalol for Airway Stress in Hypertensive Craniotomy PatientsDilevalolPhase 4Enrolling by invitationAin Shams UniversityJun 24, 2025
        PVI Alone vs PVI With Posterior Wall Isolation for Pulse-Field Ablation in Persistent AFIsoproterenolNot applicableEnrolling by invitationEwha Womans University Mokdong HospitalApr 16, 2025
        Exercise as an Immune Adjuvant for Allogeneic Cell TherapiesIsoproterenolEarly phase 1RecruitingUniversity of ArizonaOct 16, 2024
        Early Neurovascular Adaptations in Aging WomenIsoproterenolEarly phase 1RecruitingUniversity of Missouri-ColumbiaJul 25, 2024
        Epinephrine Versus Isoprenaline During Out-of-Hospital Cardiac Arrest With AsystoleIsoproterenolPhase 4Not yet recruitingUniversity of Southern DenmarkJun 25, 2024
        Safest Choice of Antihypertensive Regimen for Postpartum HypertensionDilevalolPhase 3RecruitingLoma Linda UniversitySep 22, 2022
        Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled TrialDilevalolPhase 4RecruitingNebraska Methodist Health SystemApr 4, 2022
        Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early PregnancyDilevalol—RecruitingMarshall UniversityFeb 16, 2021
        Preeclampsia Postpartum Antihypertensive TreatmentDilevalolPhase 3Active, not recruitingMedical College of WisconsinMar 6, 2020

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2094118, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.